We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unveiling Albemarle (ALB) Q1 Outlook: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
The upcoming report from Albemarle (ALB - Free Report) is expected to reveal quarterly loss of $0.62 per share, indicating a decline of 338.5% compared to the year-ago period. Analysts forecast revenues of $1.17 billion, representing a decrease of 13.9% year over year.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 192.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Albemarle metrics that are commonly tracked and forecasted by Wall Street analysts.
According to the collective judgment of analysts, 'Net Sales- Energy Storage' should come in at $588.57 million. The estimate indicates a year-over-year change of -26.5%.
The average prediction of analysts places 'Net Sales- Ketjen' at $243.93 million. The estimate indicates a year-over-year change of +0.1%.
The consensus among analysts is that 'Net Sales- Specialties' will reach $329.98 million. The estimate points to a change of +4.4% from the year-ago quarter.
Analysts expect 'Adjusted EBITDA- Corporate' to come in at -$9.39 million. Compared to the current estimate, the company reported $26.08 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Adjusted EBITDA- Ketjen' will likely reach $27.55 million. The estimate is in contrast to the year-ago figure of $21.98 million.
The consensus estimate for 'Adjusted EBITDA- Specialties' stands at $55.43 million. Compared to the current estimate, the company reported $45.18 million in the same quarter of the previous year.
Analysts predict that the 'Adjusted EBITDA- Energy Storage' will reach $132.93 million. Compared to the present estimate, the company reported $198 million in the same quarter last year.
Over the past month, shares of Albemarle have returned -22.2% versus the Zacks S&P 500 composite's -4.8% change. Currently, ALB carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Unveiling Albemarle (ALB) Q1 Outlook: Wall Street Estimates for Key Metrics
The upcoming report from Albemarle (ALB - Free Report) is expected to reveal quarterly loss of $0.62 per share, indicating a decline of 338.5% compared to the year-ago period. Analysts forecast revenues of $1.17 billion, representing a decrease of 13.9% year over year.
Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 192.9% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain Albemarle metrics that are commonly tracked and forecasted by Wall Street analysts.
According to the collective judgment of analysts, 'Net Sales- Energy Storage' should come in at $588.57 million. The estimate indicates a year-over-year change of -26.5%.
The average prediction of analysts places 'Net Sales- Ketjen' at $243.93 million. The estimate indicates a year-over-year change of +0.1%.
The consensus among analysts is that 'Net Sales- Specialties' will reach $329.98 million. The estimate points to a change of +4.4% from the year-ago quarter.
Analysts expect 'Adjusted EBITDA- Corporate' to come in at -$9.39 million. Compared to the current estimate, the company reported $26.08 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Adjusted EBITDA- Ketjen' will likely reach $27.55 million. The estimate is in contrast to the year-ago figure of $21.98 million.
The consensus estimate for 'Adjusted EBITDA- Specialties' stands at $55.43 million. Compared to the current estimate, the company reported $45.18 million in the same quarter of the previous year.
Analysts predict that the 'Adjusted EBITDA- Energy Storage' will reach $132.93 million. Compared to the present estimate, the company reported $198 million in the same quarter last year.
View all Key Company Metrics for Albemarle here>>>
Over the past month, shares of Albemarle have returned -22.2% versus the Zacks S&P 500 composite's -4.8% change. Currently, ALB carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>